Log in to save to my catalogue

In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide

In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1993180157

In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide

About this item

Full title

In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide

Publisher

New York: Springer US

Journal title

Molecular neurobiology, 2018-08, Vol.55 (8), p.6834-6840

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Delivering peptide-based drugs to the brain is a major challenge because of the existence of the blood-brain barrier (BBB). To overcome this problem, cell-penetrating peptides derived from proteins that are able to cross biological membranes have been used as cell-permeable and brain-penetrant compounds. An example is the transactivator of transcri...

Alternative Titles

Full title

In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1993180157

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1993180157

Other Identifiers

ISSN

0893-7648

E-ISSN

1559-1182

DOI

10.1007/s12035-018-0870-x

How to access this item